Skip to main content

Search

pece_annotation_1473009684

Sara_Nesheiwat

There is a separate section of the study that cites where the funding for the study came from. The study was supported by Grants-in -aid for the Cancer Control Policy from the Ministry of Health, labour and Welfare, Japan. The study also notes that the funder didn't play a role in the conduct of the study .

pece_annotation_1473577822

Sara_Nesheiwat
Annotation of

The American Red Cross has been on the forefront of research and testing, especially when it comes to blood. It was one of the first organizations to implement the testing of infectious diseases and is a single major contributor to clinical trials to improve blood safety according to their site. They were also among the first to develop testing for not only infectious disease, but HIV, Hepatitis B and C, West Nile, and Chagas disease. Currently they are actually working on a study in which they are investigating the blood supply for a tick-borne parasite in donated blood. They often work with the CDC and are always innovating ways to monitor donor blood by way of antibody recognition as well as disease detection and transmission. 

pece_annotation_1480144837

Sara_Nesheiwat

This policy was explicitly made for vulnerable populations who couldn't afford or for whatever reason did not have health insurance. The vulnerable parties that did not have health insurance were at risk of being turned away at hospitals during crucial times of need and emergency situations. This act completely absolved the worries and fears of this vulnerable population without health insurance by making it a law that these ED patients were to receive care and stabilization. This act was made for this specific vulnerable population, to prevent discrimination.